AGP Picks
View all

Science Times Observer
Provided by AGP

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on September 1, 2026

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
Sep. 1, 2026

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer

Indeterminate GlobeNewswire
Yodeck Launches AI Agent for Digital Signage Management
Sep. 1, 2026

Yodeck Launches AI Agent for Digital Signage Management

Indeterminate GlobeNewswire
REPORT: AAFA Names 2026 Asthma Capitals, Highlights Risk Factors That Increase Asthma-Related ER Visits and Deaths
Sep. 1, 2026

REPORT: AAFA Names 2026 Asthma Capitals, Highlights Risk Factors That Increase Asthma-Related ER Visits and Deaths

Indeterminate GlobeNewswire
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Sep. 1, 2026

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep. 1, 2026

Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Jade Biosciences to Participate in Upcoming Conferences
Sep. 1, 2026

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
ElevateBio Appoints Steven Falcone as Chief Operating Officer
Sep. 1, 2026

ElevateBio Appoints Steven Falcone as Chief Operating Officer

Indeterminate GlobeNewswire
ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform
Sep. 1, 2026

ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform

Indeterminate GlobeNewswire
BioCryst to Present at Upcoming Investor Conference
Sep. 1, 2026

BioCryst to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep. 1, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves
Sep. 1, 2026

Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves

Indeterminate GlobeNewswire
Satellos to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
Sep. 1, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses

Indeterminate GlobeNewswire
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences
Sep. 1, 2026

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

Indeterminate GlobeNewswire
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Sep. 1, 2026

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer
Sep. 1, 2026

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire
NOVONIX Selected for South Korea-U.S. Infrastructure Initiative
Sep. 1, 2026

NOVONIX Selected for South Korea-U.S. Infrastructure Initiative

Indeterminate GlobeNewswire
VR Releases AGM Results and Provides Update on Empire Transaction
Sep. 1, 2026

VR Releases AGM Results and Provides Update on Empire Transaction

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Times Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.